Its been a fantastic turnaround in recent years for Aviva (LSE: AV) (NYSE: AV.US), with its current management team successfully changing the operations of the business so as to deliver much-improved bottom line performance. In fact, shares in the company have risen by 14% in the last year alone and, looking ahead, a further 20% rise seems to be a very realistic target. Heres why Aviva could make those gains and reach 660p per share.
Growth Potential
Although Avivas bottom line is forecast to increase by a rather lowly 4% this year, the insurer is expected to deliver much stronger gains in 2016. In fact, Avivas earnings are due to grow by 15% next year, which is a considerably higher rate of growth than the FTSE 100, and shows that Avivas current strategy of disposing of riskier and lower reward divisions is proving to be a successful one. And, with there being a considerable amount of rationalisation yet to come, Aviva could continue to surprise on the upside when it comes to its bottom line prospects for the medium to long term.
Valuation
Despite having the potential to grow profit at a much faster rate than the wider index, Aviva is still priced at a sizeable discount. For example, it has a price to earnings (P/E) ratio of just 11.1, while the FTSE 100s P/E is much higher at around 16. As such, Aviva could see its share price trade at 660p through there being an upward rerating to its valuation that still leaves it trading at a discount to the wider sector.
For example, a P/E ratio of 13.5 would be sufficient for Avivas shares to trade at 660p, and yet this would still leave them at a sizeable discount to the FTSE 100s P/E ratio. As such, a price target of 660p seems to be very achievable for Aviva over the medium term.
Looking Ahead
While Avivas share price will not move higher all on its own, there seems to be sufficient news flow in the pipeline to change investor sentiment sufficiently to push its rating higher. Notably, there is the merger with Friends Life that could cause investors to rethink their views on how Aviva can continue to generate upbeat earnings growth (i.e. through cost savings rather than purely through revenue growth), while the companys rationalisation plans have yet to be fully completed, which may also mean further improvements in profitability moving forward.
Therefore, while the reaching of 660p would represent impressive performance over the medium term, Aviva is a stock with huge long term potential. As such, it seems to be well worth buying at the present time, with very appealing gains being on offer as the company continues to go from strength to strength.
Of course, Aviva isn’t the only stock that could boost your portfolio returns. However, finding the best stocks at the lowest prices can be tough when work and other commitments get in the way.
That’s why The Motley Fool has written a free and without obligation guide called 7 Simple Steps For Seeking Serious Wealth.
It’s a step-by-step guide that could make a real difference to your financial future and, in time, could help you to retire early, pay off the mortgage, or simply enjoy a more abundant lifestyle.
Click here to get your copy of the guide – it’s completely free and comes without any obligation.
Get FREE Issues of The Motley Fool Collective
Get straightforward advice on whats really happening with the stock markets, direct to your inbox. Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio wealth.
By providing your email address, you consent to receiving further information on our goods and services and those of our business partners. To opt-out of receiving this information click here. All information provided is governed by our Privacy Statement.
Peter Stephens owns shares of Aviva and Friends Life. The Motley Fool UK has no position in any of the shares mentioned. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.